Showing results (1-10 of 6,949) with videos related to
Sort By:
Pageof 695
Oncoimmunology|March 26, 2013
Strong emerging rationale for combining oncogene-targeted agents with immunotherapyYan Yang, Gregory Lizée, Patrick HwuOncoimmunology|March 26, 2013
Blockade of the PD-1 pathway enhances the efficacy of adoptive cell therapy against cancerWeiyi Peng, Gregory Lizée, Patrick HwuOncoimmunology|March 26, 2013
Forging a link between oncogenic signaling and immunosuppression in melanomaJahan S Khalili, Patrick Hwu, Gregory LizéeClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Less yin, more yang: confronting the barriers to cancer immunotherapyGregory Lizée, Mayra A Cantu, Patrick HwuClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Immunosuppression in melanoma immunotherapy: potential opportunities for interventionGregory Lizée, Laszlo G Radvanyi, Willem W Overwijk, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Improving antitumor immune responses by circumventing immunoregulatory cells and mechanismsGregory Lizée, Laszlo G Radvanyi, Willem W Overwijk, et al.Blood|September 1, 2012
Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40Yan Yang, Chengwen Liu, Weiyi Peng, et al.Cancer Treatment and Research|November 26, 2015
Novel Treatments in Development for MelanomaChantale Bernatchez, Zachary A Cooper, Jennifer A Wargo, et al.Annual Review of Medicine|October 25, 2012
Harnessing the power of the immune system to target cancerGregory Lizée, Willem W Overwijk, Laszlo Radvanyi, et al.International Immunology|September 28, 2007
IL-21 synergizes with IL-7 to augment expansion and anti-tumor function of cytotoxic T cellsShujuan Liu, Gregory Lizée, Yanyan Lou, et al.Pageof 695